Pancreatic Cancer Research

ResearcherGarvan Institute of Medical ResearchActive in the last 2 years

Kara L. Vine

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6871-1149; OpenAlex author ID A5060335037. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 9

  1. Localized Delivery of Anti-CD40/PD-1 Immunotherapy via a Polymeric Implant is Efficacious, Remodels the Tumor Immune Microenvironment and Improves Safety in a … Last author DOI 10.1002/adhm.202503780↗
  2. Efficacy and Safety Assessment of 5-Fluorouracil, Irinotecan and Oxaliplatin-Loaded Implants in Mouse and Pig Models for Pancreatic Cancer Therapy. Last author DOI 10.1002/adma.202522617↗
  3. Neoadjuvant chemotherapy induces transient, regimen-specific immune–stromal reprogramming in pancreatic ductal adenocarcinoma Last author DOI 10.64898/2026.09.07.749769↗
  4. Gut microbial diversity is preserved through localised chemo-immunotherapy delivery in a KPC mouse model of pancreatic cancer. Last author DOI 10.1016/j.jconrel.2025.114143↗
  5. Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds. Last author DOI 10.1016/j.jconrel.2024.07.023↗
  6. Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model. Last author DOI 10.1371/journal.pcbi.1010104↗
  7. Dual Delivery of Gemcitabine and Paclitaxel by Wet-Spun Coaxial Fibers Induces Pancreatic Ductal Adenocarcinoma Cell Death, Reduces Tumor Volume, and Sensitize… Last author DOI 10.1002/adhm.202001115↗
  8. Preparation and in vitro assessment of wet-spun gemcitabine-loaded polymeric fibers: Towards localized drug delivery for the treatment of pancreatic cancer. Last author DOI 10.1016/j.pan.2017.06.001↗
  9. SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer. Co-author DOI 10.1038/onc.2017.63↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Samantha J. Wade · 7 shared papers, 2017–2026 · strength 1.43
  2. Elahe Minaei · 5 shared papers, 2024–2026 · strength 1.34
  3. Marie Ranson · 5 shared papers, 2017–2026 · strength 1.17
  4. Koroush Shahsavar Haghighi · 1 shared paper, 2026 · strength 0.24
  5. Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.24
  6. Ashna A. Kumar · 1 shared paper, 2026 · strength 0.23
  7. Phoebe A. Phillips · 1 shared paper, 2026 · strength 0.23
  8. George Sharbeen · 1 shared paper, 2026 · strength 0.23
  9. Adrianne L. Jenner · 1 shared paper, 2023 · strength 0.18
  10. Claire Vennin · 1 shared paper, 2017 · strength 0.06
  11. Marina Pajic · 1 shared paper, 2017 · strength 0.06
  12. David Herrmann · 1 shared paper, 2017 · strength 0.06
  13. Mark J. Cowley · 1 shared paper, 2017 · strength 0.06
  14. Darren N. Saunders · 1 shared paper, 2017 · strength 0.06
  15. James R. W. Conway · 1 shared paper, 2017 · strength 0.06
  16. Australian Pancreatic Cancer Genome Initiative · 1 shared paper, 2017 · strength 0.06
  17. Jennifer P. Morton · 1 shared paper, 2017 · strength 0.06
  18. Paul Timpson · 1 shared paper, 2017 · strength 0.06
  19. Andrew Victor Biankin · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.